UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 288

Sortiert nach

The clinical relevance of KRAS gene mutation in non-small-cell lung cancer

Current opinion in oncology, 2014-03, Vol.26 (2), p.138-144

Tímár, József

2014

Link zum Volltext

Verfügbarkeit prüfen

On-Target Side Effects of Targeted Therapeutics of Cancer

Pathology oncology research, 2022-09, Vol.28, p.1610694-1610694

2022

Link zum Volltext

Verfügbarkeit prüfen

KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges

Pathology oncology research, 2024-01, Vol.29, p.1611580-1611580

2024

Link zum Volltext

Verfügbarkeit prüfen

Immunologic and immunogenomic aspects of tumor progression

Seminars in cancer biology, 2020-02, Vol.60, p.249-261

2020

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia Signaling in Cancer: From Basics to Clinical Practice

Pathology oncology research, 2021-05, Vol.27, p.1609802-1609802

2021

Link zum Volltext

Verfügbarkeit prüfen

Metastatic Progression of Human Melanoma

Cancers, 2023-02, Vol.15 (4), p.1225

2023

Link zum Volltext

Verfügbarkeit prüfen

RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.1025-1034

2012

Link zum Volltext

Verfügbarkeit prüfen

Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development

International journal of molecular sciences, 2024-02, Vol.25 (5), p.2572

2024

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Pathology and Oncology Research: addressing publication ethics issues

Pathology oncology research, 2024-02, Vol.30, p.1611691-1611691

2024

Link zum Volltext

Verfügbarkeit prüfen

Scientific integrity in the era of predatory journals: Insights from an editors in chief symposium

British journal of pharmacology, 2024-08, Vol.181 (15), p.2387-2390

2024

Link zum Volltext

Verfügbarkeit prüfen

Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells

BMC cancer, 2018-10, Vol.18 (1), p.1029-1029, Article 1029

2018

Link zum Volltext

Verfügbarkeit prüfen

The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner

PloS one, 2017-11, Vol.12 (11), p.e0187094-e0187094

2017

Link zum Volltext

Verfügbarkeit prüfen

Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging

Analytical and bioanalytical chemistry, 2012-06, Vol.403 (8), p.2315-2325

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparison of standard mismatch repair deficiency and microsatellite instability tests in a large cancer series

Journal of translational medicine, 2024-02, Vol.22 (1), p.150-9, Article 150

2024

Link zum Volltext

Verfügbarkeit prüfen

Alternative Vascularization Mechanisms in Cancer: Pathology and Therapeutic Implications

The American journal of pathology, 2007-01, Vol.170 (1), p.1-15

2007

Link zum Volltext

Verfügbarkeit prüfen

Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors

British journal of cancer, 2024-04, Vol.130 (6), p.1059-1072

2024

Link zum Volltext

Verfügbarkeit prüfen

Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?

Pathology oncology research, 2024-04, Vol.30, p.1611719-1611719

2024

Link zum Volltext

Verfügbarkeit prüfen

Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations

International journal of molecular sciences, 2020-10, Vol.21 (20), p.7649

2020

Link zum Volltext

Verfügbarkeit prüfen

The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb

International journal of molecular sciences, 2019-10, Vol.20 (19), p.4917

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas

Oral oncology, 2011-06, Vol.47 (6), p.487-496

2011

Link zum Volltext

Verfügbarkeit prüfen

NSCLC molecular testing in Central and Eastern European countries

BMC cancer, 2018-03, Vol.18 (1), p.269-269, Article 269

2018

Link zum Volltext

Verfügbarkeit prüfen

The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries

Cancers, 2023-03, Vol.15 (6), p.1712

2023

Link zum Volltext

Verfügbarkeit prüfen

Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells

BMC cancer, 2018-05, Vol.18 (1), p.542-11, Article 542

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy

International journal of molecular sciences, 2022-02, Vol.23 (5), p.2704

2022

Link zum Volltext

Verfügbarkeit prüfen

Cell migration or cytokinesis and proliferation? – Revisiting the “go or grow” hypothesis in cancer cells in vitro

Experimental cell research, 2013-12, Vol.319 (20), p.3094-3103

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 288

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer And Metastasis Reviews

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(234)

Publikationsform

Artikel
(288)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The clinical relevance of KRAS gene mutation in non-small-cell lung cancer

On-Target Side Effects of Targeted Therapeutics of Cancer

KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges

Immunologic and immunogenomic aspects of tumor progression

Hypoxia Signaling in Cancer: From Basics to Clinical Practice

Metastatic Progression of Human Melanoma

RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data

Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development

Editorial: Pathology and Oncology Research: addressing publication ethics issues

Scientific integrity in the era of predatory journals: Insights from an editors in chief symposium

Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells

The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner

Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging

Comparison of standard mismatch repair deficiency and microsatellite instability tests in a large cancer series

Alternative Vascularization Mechanisms in Cancer: Pathology and Therapeutic Implications

Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors

Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?

Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations

The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb

Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas

NSCLC molecular testing in Central and Eastern European countries

The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries

Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells

Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy

Cell migration or cytokinesis and proliferation? – Revisiting the “go or grow” hypothesis in cancer cells in vitro

Aktive Filter

Suchergebnisse filtern